Valerion Therapeutics, LLC
Records under this name other than the patents Valerion Therapeutics, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 7 of 7 · Back to Valerion Therapeutics, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,447,394 | Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides Lapsed on the fee record Ended Sep 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2024 | From the USPTO record |
| US 10,501,554 | Internalizing moieties for treatment of cancer Lapsed on the fee record Ended Dec 10, 2023 · From the USPTO record | Lapsed on the fee record | Ended Dec 10, 2023 | From the USPTO record |
| US 9,114,178 | Methods and Compositions for Treatment of Myotonic Dystrophy Lapsed on the fee record Ended Aug 25, 2023 · Medium confidence | Lapsed on the fee record | Ended Aug 25, 2023 | Medium confidence |
| US 8,834,866 | Methods and compositions for treatment of myotubular myopathy using chimeric polypeptides comprising myotubularin 1(MTM1) polypeptides Lapsed on the fee record Ended Sep 16, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 16, 2022 | From the USPTO record |
| US 10,017,581 | Methods and compositions for treatment of Pompe disease Lapsed on the fee record Ended Jul 10, 2022 · From the USPTO record | Lapsed on the fee record | Ended Jul 10, 2022 | From the USPTO record |
| US 8,609,615 | Methods and compositions for treatment of myotonic dystrophy Lapsed on the fee record Ended Dec 17, 2021 · High confidence | Lapsed on the fee record | Ended Dec 17, 2021 | High confidence |
| US 9,610,362 | Antisense conjugates for decreasing expression of DMPK Lapsed on the fee record Ended Apr 4, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2021 | From the USPTO record |